vs
Apellis Pharmaceuticals, Inc.（APLS）与MGP INGREDIENTS INC（MGPI）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是MGP INGREDIENTS INC的1.4倍（$199.9M vs $138.3M），Apellis Pharmaceuticals, Inc.净利率更高（-29.5% vs -97.3%，领先67.8%），Apellis Pharmaceuticals, Inc.同比增速更快（-5.9% vs -23.5%），MGP INGREDIENTS INC自由现金流更多（$24.3M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -9.9%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
MGP配料公司是总部位于美国的优质蒸馏酒、特种小麦和玉米基淀粉及蛋白质配料供应商，服务食品饮料制造、餐饮及工业客户领域，为北美及部分全球市场客户提供定制化配料解决方案。
APLS vs MGPI — 直观对比
营收规模更大
APLS
是对方的1.4倍
$138.3M
营收增速更快
APLS
高出17.6%
-23.5%
净利率更高
APLS
高出67.8%
-97.3%
自由现金流更多
MGPI
多$38.5M
$-14.3M
两年增速更快
APLS
近两年复合增速
-9.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $138.3M |
| 净利润 | $-59.0M | $-134.6M |
| 毛利率 | — | 34.9% |
| 营业利润率 | -25.6% | -97.7% |
| 净利率 | -29.5% | -97.3% |
| 营收同比 | -5.9% | -23.5% |
| 净利润同比 | -62.2% | -220.8% |
| 每股收益（稀释后） | $-0.40 | $-6.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSMGPI
| Q4 25 | $199.9M | $138.3M | ||
| Q3 25 | $458.6M | $130.9M | ||
| Q2 25 | $178.5M | $145.5M | ||
| Q1 25 | $166.8M | $121.7M | ||
| Q4 24 | $212.5M | $180.8M | ||
| Q3 24 | $196.8M | $161.5M | ||
| Q2 24 | $199.7M | $190.8M | ||
| Q1 24 | $172.3M | $170.6M |
净利润APLSMGPI
| Q4 25 | $-59.0M | $-134.6M | ||
| Q3 25 | $215.7M | $15.4M | ||
| Q2 25 | $-42.2M | $14.4M | ||
| Q1 25 | $-92.2M | $-3.0M | ||
| Q4 24 | $-36.4M | $-42.0M | ||
| Q3 24 | $-57.4M | $23.9M | ||
| Q2 24 | $-37.7M | $32.1M | ||
| Q1 24 | $-66.4M | $20.6M |
毛利率APLSMGPI
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 37.8% | ||
| Q2 25 | — | 40.1% | ||
| Q1 25 | — | 35.6% | ||
| Q4 24 | — | 41.2% | ||
| Q3 24 | — | 40.8% | ||
| Q2 24 | — | 43.6% | ||
| Q1 24 | — | 36.8% |
营业利润率APLSMGPI
| Q4 25 | -25.6% | -97.7% | ||
| Q3 25 | 48.7% | 16.1% | ||
| Q2 25 | -18.6% | 14.0% | ||
| Q1 25 | -50.0% | -0.6% | ||
| Q4 24 | -12.3% | -16.8% | ||
| Q3 24 | -24.0% | 20.2% | ||
| Q2 24 | -14.7% | 22.7% | ||
| Q1 24 | -36.0% | 17.0% |
净利率APLSMGPI
| Q4 25 | -29.5% | -97.3% | ||
| Q3 25 | 47.0% | 11.8% | ||
| Q2 25 | -23.6% | 9.9% | ||
| Q1 25 | -55.3% | -2.5% | ||
| Q4 24 | -17.1% | -23.2% | ||
| Q3 24 | -29.2% | 14.8% | ||
| Q2 24 | -18.9% | 16.8% | ||
| Q1 24 | -38.5% | 12.1% |
每股收益（稀释后）APLSMGPI
| Q4 25 | $-0.40 | $-6.23 | ||
| Q3 25 | $1.67 | $0.71 | ||
| Q2 25 | $-0.33 | $0.67 | ||
| Q1 25 | $-0.74 | $-0.14 | ||
| Q4 24 | $-0.30 | $-1.86 | ||
| Q3 24 | $-0.46 | $1.07 | ||
| Q2 24 | $-0.30 | $1.43 | ||
| Q1 24 | $-0.54 | $0.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $18.5M |
| 总债务越低越好 | — | $245.9M |
| 股东权益账面价值 | $370.1M | $718.4M |
| 总资产 | $1.1B | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.34× |
8季度趋势，按日历期对齐
现金及短期投资APLSMGPI
| Q4 25 | $466.2M | $18.5M | ||
| Q3 25 | $479.2M | $13.4M | ||
| Q2 25 | $370.0M | $17.3M | ||
| Q1 25 | $358.4M | $20.1M | ||
| Q4 24 | $411.3M | $25.3M | ||
| Q3 24 | $396.9M | $20.8M | ||
| Q2 24 | $360.1M | $21.0M | ||
| Q1 24 | $325.9M | $19.5M |
总债务APLSMGPI
| Q4 25 | — | $245.9M | ||
| Q3 25 | — | $262.3M | ||
| Q2 25 | — | $290.7M | ||
| Q1 25 | — | $290.7M | ||
| Q4 24 | — | $317.1M | ||
| Q3 24 | — | $283.6M | ||
| Q2 24 | — | $303.0M | ||
| Q1 24 | $93.1M | $294.4M |
股东权益APLSMGPI
| Q4 25 | $370.1M | $718.4M | ||
| Q3 25 | $401.2M | $855.2M | ||
| Q2 25 | $156.3M | $841.8M | ||
| Q1 25 | $164.2M | $828.3M | ||
| Q4 24 | $228.5M | $834.2M | ||
| Q3 24 | $237.1M | $914.5M | ||
| Q2 24 | $264.3M | $894.5M | ||
| Q1 24 | $266.7M | $867.0M |
总资产APLSMGPI
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $821.4M | $1.4B | ||
| Q1 25 | $807.3M | $1.4B | ||
| Q4 24 | $885.1M | $1.4B | ||
| Q3 24 | $901.9M | $1.4B | ||
| Q2 24 | $904.5M | $1.4B | ||
| Q1 24 | $831.9M | $1.4B |
负债/权益比APLSMGPI
| Q4 25 | — | 0.34× | ||
| Q3 25 | — | 0.31× | ||
| Q2 25 | — | 0.35× | ||
| Q1 25 | — | 0.35× | ||
| Q4 24 | — | 0.38× | ||
| Q3 24 | — | 0.31× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | 0.35× | 0.34× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $29.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $24.3M |
| 自由现金流率自由现金流/营收 | -7.1% | 17.5% |
| 资本支出强度资本支出/营收 | 0.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $76.0M |
8季度趋势，按日历期对齐
经营现金流APLSMGPI
| Q4 25 | $-14.2M | $29.1M | ||
| Q3 25 | $108.5M | $36.1M | ||
| Q2 25 | $4.4M | $11.7M | ||
| Q1 25 | $-53.4M | $44.7M | ||
| Q4 24 | $19.4M | $28.8M | ||
| Q3 24 | $34.1M | $43.9M | ||
| Q2 24 | $-8.3M | $5.0M | ||
| Q1 24 | $-133.0M | $24.6M |
自由现金流APLSMGPI
| Q4 25 | $-14.3M | $24.3M | ||
| Q3 25 | $108.3M | $27.6M | ||
| Q2 25 | $4.4M | $-557.0K | ||
| Q1 25 | $-53.4M | $24.8M | ||
| Q4 24 | $19.3M | $10.4M | ||
| Q3 24 | — | $24.5M | ||
| Q2 24 | $-8.4M | $-1.4M | ||
| Q1 24 | $-133.3M | $-2.4M |
自由现金流率APLSMGPI
| Q4 25 | -7.1% | 17.5% | ||
| Q3 25 | 23.6% | 21.1% | ||
| Q2 25 | 2.5% | -0.4% | ||
| Q1 25 | -32.0% | 20.4% | ||
| Q4 24 | 9.1% | 5.8% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | -4.2% | -0.7% | ||
| Q1 24 | -77.3% | -1.4% |
资本支出强度APLSMGPI
| Q4 25 | 0.1% | 3.5% | ||
| Q3 25 | 0.0% | 6.5% | ||
| Q2 25 | 0.0% | 8.4% | ||
| Q1 25 | 0.0% | 16.4% | ||
| Q4 24 | 0.0% | 10.1% | ||
| Q3 24 | 0.0% | 12.0% | ||
| Q2 24 | 0.0% | 3.3% | ||
| Q1 24 | 0.2% | 15.8% |
现金转化率APLSMGPI
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 2.34× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.84× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 1.19× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
MGPI
| Branded Spirits | $63.4M | 46% |
| Ingredient Solutions | $31.3M | 23% |
| Specialty Wheat Starches | $16.8M | 12% |
| Mid Spirits | $16.1M | 12% |
| Other Branded Spirits | $8.0M | 6% |
| Commodity Wheat Starch | $2.3M | 2% |
